Pavan Parikh, MD in Portland, OR - Medicare Obstetrics/gynecology

Pavan Parikh, MD is a medicare enrolled "Obstetrics & Gynecology - Maternal & Fetal Medicine" physician in Portland, Oregon. He graduated from medical school in 2012 and has 12 years of diverse experience with area of expertise as Obstetrics/gynecology. He is a member of the group practice Oregon Health And Sciences University/university Medical Group, Salem Health and his current practice location is 3181 Sw Sam Jackson Park Rd, Portland, Oregon. You can reach out to his office (for appointments etc.) via phone at (503) 418-4500.

Pavan Parikh is licensed to practice in Oregon (license number MD214410) and he also participates in the medicare program. He accepts medicare assignments (which means he accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance) and his NPI Number is 1427312891.

Contact Information

	Pavan Parikh, MD
	3181 Sw Sam Jackson Park Rd, Portland, OR 97239-3011
	(503) 418-4500
	(503) 494-1678

Physician's Profile

Full Name	Pavan Parikh
Gender	Male
Speciality	Obstetrics/gynecology
Experience	12 Years
Location	3181 Sw Sam Jackson Park Rd, Portland, Oregon
Accepts Medicare Assignments	Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance.

Medical Education and Training:

Pavan Parikh graduated from medical school in 2012

NPI Data:

NPI Number: 1427312891
Provider Enumeration Date: 06/29/2012
Last Update Date: 05/19/2023

Medicare PECOS Information:

PECOS PAC ID: 9436475449
Enrollment ID: I20230310000504

Medical Identifiers

Medical identifiers for Pavan Parikh such as npi, medicare ID, medicare PIN, medicaid, etc.

Identifier	Type	State	Issuer
1427312891	NPI	-	NPPES

Medical Taxonomies and Licenses

Taxonomy	Type	License (State)	Status
207V00000X	Obstetrics & Gynecology	60547 (Minnesota)	Secondary
207V00000X	Obstetrics & Gynecology	MD214410 (Oregon)	Secondary
207VM0101X	Obstetrics & Gynecology - Maternal & Fetal Medicine	34301 (Oklahoma)	Secondary
207VM0101X	Obstetrics & Gynecology - Maternal & Fetal Medicine	60547 (Minnesota)	Secondary
207VM0101X	Obstetrics & Gynecology - Maternal & Fetal Medicine	MD214410 (Oregon)	Primary

Group Practice Association

Group Practice Name	Group PECOS PAC ID	No. of Members
Oregon Health And Sciences University/university Medical Group	4880760107	1485
Salem Health	8628986668	387

News Archive

SCOLR Pharma total revenue decreases 34% to $618,000 for 2010

SCOLR Pharma, Inc. today reported financial results for the twelve months ended December 31, 2010, and also provided updates on a number of key corporate objectives.

States target vaping with bans. In California, the action is local.

States are piling on. Michigan took the first statewide shot at vaping early this month when it announced a ban on the sale of flavored e-cigarette products. It was soon joined by New York, and Rhode Island jumped in Wednesday. Massachusetts went further, announcing Tuesday that it would prohibit the sale of all vaping flavors and devices for four months.

Diet rich in fiber may reduce risk of developing lung disease

A diet rich in fiber may not only protect against diabetes and heart disease, it may reduce the risk of developing lung disease, according to new research published online, ahead of print in the Annals of the American Thoracic Society.

FDA continues review of Salix's Crofelemer new drug application

Napo Pharmaceuticals, Inc. was informed today that the Food and Drug Administration is continuing its review of the new drug application seeking approval of crofelemer for the treatment of chronic diarrhea in people living with HIV/AIDS on anti-retroviral therapy.

Medicare Reassignments

Some practitioners may not bill the customers directly but medicare billing happens through clinics / group practice / hospitals where the provider works. Medicare reassignment of benefits is a mechanism by which practitioners allow third parties to bill and receive payment for medicare services performed by them. Pavan Parikh allows following entities to bill medicare on his behalf.

Entity Name	Salem Health
Entity Type	Part B Supplier - Clinic/group Practice
Entity Identifiers	NPI Number: 1265431829 PECOS PAC ID: 8628986668 Enrollment ID: O20040309001131

News Archive

SCOLR Pharma total revenue decreases 34% to $618,000 for 2010

SCOLR Pharma, Inc. today reported financial results for the twelve months ended December 31, 2010, and also provided updates on a number of key corporate objectives.

States target vaping with bans. In California, the action is local.

Diet rich in fiber may reduce risk of developing lung disease

FDA continues review of Salix's Crofelemer new drug application

Entity Name	University Professional Services
Entity Type	Part B Supplier - Clinic/group Practice
Entity Identifiers	NPI Number: 1376709535 PECOS PAC ID: 4880760107 Enrollment ID: O20080910000013

SCOLR Pharma total revenue decreases 34% to $618,000 for 2010

SCOLR Pharma, Inc. today reported financial results for the twelve months ended December 31, 2010, and also provided updates on a number of key corporate objectives.

States target vaping with bans. In California, the action is local.

Diet rich in fiber may reduce risk of developing lung disease

FDA continues review of Salix's Crofelemer new drug application

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Pavan Parikh is enrolled with medicare and thus, if eligible, can prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing Address	Practice Location Address
Pavan Parikh, MD 3181 Sw Sam Jackson Park Rd, Portland, OR 97239-3011 Ph: (503) 418-4500	Pavan Parikh, MD 3181 Sw Sam Jackson Park Rd, Portland, OR 97239-3011 Ph: (503) 418-4500

News Archive

SCOLR Pharma total revenue decreases 34% to $618,000 for 2010

SCOLR Pharma, Inc. today reported financial results for the twelve months ended December 31, 2010, and also provided updates on a number of key corporate objectives.

States target vaping with bans. In California, the action is local.

Diet rich in fiber may reduce risk of developing lung disease

FDA continues review of Salix's Crofelemer new drug application

Obstetrics & Gynecology Doctors in Portland, OR

Dr. Rachel L Gutfreund, MD Obstetrics & Gynecology Medicare: Medicare Enrolled Practice Location: 10101 Se Main St Ste 3001, Portland, OR 97216 Phone: 503-261-4423 Fax: 503-261-4424
John Gilbert Buckmaster, MD Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 3181 Sw Sam Jackson Park Rd, Portland, OR 97239 Phone: 503-494-4200
Darlene J Dodson, M.D. Obstetrics & Gynecology Medicare: Medicare Enrolled Practice Location: 9205 Sw Barnes Rd Fl 3, Portland, OR 97225 Phone: 503-216-3388
Antonio E Frias, MD Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 3181 Sw Sam Jackson Park Rd, Portland, OR 97239 Phone: 503-418-4200 Fax: 503-494-4473
Sig-linda Jacobson, M.D. Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 5006 Sw Martha St, Portland, OR 97221 Phone: 503-806-7854
Laila Raad Sillay, MD Obstetrics & Gynecology Medicare: Not Enrolled in Medicare Practice Location: 9555 Sw Barnes Rd Ste 360, Portland, OR 97225 Phone: 503-445-0590
Edward Paul Kirk, MD Obstetrics & Gynecology Medicare: Not Enrolled in Medicare Practice Location: 3181 Sw Sam Jackson Park Rd, Portland, OR 97239 Phone: 503-494-4500

Pavan Parikh, MD - Medicare Obstetrics/gynecology in Portland, OR

Contact Information

Physician's Profile

Medical Identifiers

Medical Taxonomies and Licenses

Group Practice Association

SCOLR Pharma total revenue decreases 34% to $618,000 for 2010

States target vaping with bans. In California, the action is local.

Diet rich in fiber may reduce risk of developing lung disease

FDA continues review of Salix's Crofelemer new drug application

Medicare Reassignments

SCOLR Pharma total revenue decreases 34% to $618,000 for 2010

States target vaping with bans. In California, the action is local.

Diet rich in fiber may reduce risk of developing lung disease

FDA continues review of Salix's Crofelemer new drug application

SCOLR Pharma total revenue decreases 34% to $618,000 for 2010

States target vaping with bans. In California, the action is local.

Diet rich in fiber may reduce risk of developing lung disease

FDA continues review of Salix's Crofelemer new drug application

Medicare Part D Prescriber Enrollment

Mailing Address and Practice Location

SCOLR Pharma total revenue decreases 34% to $618,000 for 2010

States target vaping with bans. In California, the action is local.

Diet rich in fiber may reduce risk of developing lung disease

FDA continues review of Salix's Crofelemer new drug application

Obstetrics & Gynecology Doctors in Portland, OR